Nurse Practitioner in Grindstone, PA Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Michele Renee Reed, PMHNP-BC Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 111 Roberts Rd, Grindstone, PA 15442 Phone: 724-785-4346 |
Ashley Lauren Tonsetic, CRNP Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 111 Roberts Rd Ste 150, Grindstone, PA 15442 Phone: 724-785-4346 Fax: 724-364-7117 |
News Archive
Compound found in the peels of citrus fruit can potentially lower cholesterol more effectively than prescription drugs
A compound found in the peels of citrus fruit has the potential to lower cholesterol more effectively than some prescription drugs, and without side effects, according to a study by U.S. and Canadian researchers.
Patient satisfaction a poor proxy for quality of care in elective cranial neurosurgery
Patient satisfaction is a very poor proxy for quality of care comparisons in elective cranial neurosurgery. Because deaths are rare events in elective cranial neurosurgery, reporting of surgeon or even department-specific mortality figures cannot differentiate a high or low level of the quality of care.
Top-line results from Inhibitex's FV-100 Phase II clinical trial for treatment of shingles
Inhibitex, Inc. today reported top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily doses of FV-100 (200 mg and 400 mg) to an active control, valacyclovir, one of the most commonly-used antiviral drugs to treat shingles.
Repligen expects total revenue of $21.0M for fiscal year 2010
Repligen Corporation today announced preliminary financial results for fiscal year 2010 which ended March 31, 2010. Total revenue for the year is expected to be $21.0 million, including $10.3 million of bioprocessing product revenue and $10.7 million of royalty and other revenue. Research and development expenses are expected to be between $13.8-$14.2 million and selling, general and administrative expenses between $6.8-$7.2 million.
Molecular beacons allow scientists to monitor gene expression during stem cell transformation
A novel set of custom-designed "molecular beacons" allows scientists to monitor gene expression in living populations of stem cells as they turn into a specific tissue in real-time. The technology, which Brown University researchers describe in a new study, provides tissue engineers with a potentially powerful tool to discover what it may take to make stem cells transform into desired tissue cells more often and more quickly.
› Verified 5 days ago